Ines Foessl et al, Nov. 2021
Ines Foessl1, Duncan Bassett2, Åshild Bjørnerem3, Björn Busse4, Ângelo M. Calado5, Pascale Chavassieux6, Maria Christou7, Eleni Douni8, 9, Imke Fiedler4, João E. Fonseca5, 10, Eva Hassler11, Wolfgang Högler12, Erika Kague13, David Karasik14, Patricia Khashayar15, Bente L. Langdahl16, Victoria D. Leitch17, Philippe Lopes18, Georgios Markozannes7, Fiona McGuigan19, Carolina Medina-Gomez20, Evangelia Ntzani7, 21, Ling Oei20, Claes Ohlsson22, Pawel Szulc6, Jonathan H. Tobias23, 24, Katerina Trajanoska20, Şansın Tuzun25, Amina Valjevac26, Bert van Rietbergen27, Graham R. Williams2, Tatjana Zekic28, Fernando Rivadeneira20 and Barbara Obermayer-Pietsch1*
- 1Department of Internal Medicine, Division of Endocrinology and Diabetology, Endocrine Lab Platform, Medical University of Graz, Austria
- 2Molecular Endocrinology Laboratory, Department of Metabolism, Digestion and Reproduction, Hammersmith Campus, Imperial College London, United Kingdom
- 3Department of Clinical Medicine, UiT The Arctic University of Norway, Norway
- 4Department of Osteology and Biomechanics, University Medical Center Hamburg-Eppendorf, Germany
- 5Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Centro Académico de Medicina de Lisboa, Portugal
- 6INSERM UMR 1033, Université de Lyon, France
- 7Department of Hygiene and Epidemiology, Medical School, University of Ioannina, Greece
- 8Institute for Bioinnovation, B.S.R.C. “Alexander Fleming”, Greece
- 9Department of Biotechnology, Agricultural University of Athens, Greece
- 10Rheumatology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, EPE CHLN, Portugal
- 11Division of Neuroradiology, Vascular and Interventional Radiology, Department of Radiology, Medical University of Graz, Austria
- 12Department of Paediatrics and Adolescent Medicine, Johannes Kepler University Linz, Austria
- 13School of Physiology, Pharmacology and Neuroscience, Faculty of Biomedical Sciences, University of Bristol, United Kingdom
- 14Azrieli Faculty of Medicine, Bar-Ilan University, Israel
- 15Center for Microsystems Technology, Imec and Ghent University, Belgium
- 16Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Denmark
- 17Innovative Manufacturing Cooperative Research Centre, RMIT University, School of Engineering, Australia
- 18Laboratoire de Biologie de l’Exercice pour la Performance et la Santé (LBEPS), Univ Evry, IRBA, Université Paris Saclay, France
- 19Department of Clinical Sciences, Faculty of Medicine, Lund University, Sweden
- 20Department of Internal Medicine, Erasmus Medical Center, Netherlands
- 21Department of Health Services, Policy and Practice, Center for Research Synthesis in Health, School of Public Health, Brown University, United States
- 22Centre for Bone and Arthritis Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden
- 23Musculoskeletal Research Unit, Translational Health Sciences, Bristol Medical School, University of Bristol, United Kingdom
- 24MRC Integrative Epidemiology Unit, University of Bristol, United Kingdom
- 25Istanbul University-Cerrahpaşa, Cerrahpasa Medical Faculty, Physical Medicine and Rehabilitation Department, Turkey
- 26Department of Physiology, Medical Faculty University of Sarajevo, Bosnia and Herzegovina
- 27Department of Biomedical Engineering, Eindhoven University of Technology, Netherlands
- 28Department of Rheumatology and Clinical Immunology, Faculty of Medicine, Clinical Hospital Center Rijeka, University of Rijeka, Croatia
A synoptic overview of scientific methods applied in bone and associated research fields across species has yet to be published. Experts from the EU Cost Action GEMSTONE (“GEnomics of MusculoSkeletal Traits translational Network”) Working Group 2 present an overview of the routine techniques as well as clinical and research approaches employed to characterize bone phenotypes in humans and selected animal models (mice and zebrafish) of health and disease. The goal is consolidation of knowledge and a map for future research. This expert paper provides a comprehensive overview of state-of-the-art technologies to investigate bone properties in humans and animals – including their strengths and weaknesses. New research methodologies are outlined and future strategies are discussed to combine phenotypic with rapidly developing –omics data in order to advance musculoskeletal research and move towards “personalised medicine”.
Read the full paper here